Search
for
Sort by
Research 271–300 of 1000+
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Efficacy and safety of a dietary supplement containing a lipid co-extract from Serenoa repens and Pygeum africanum for the treatment of androgenetic alopecia (AGA) in women. Results of a randomized, double-blind, placebo-controlled clinical trial
- Titagen® for total wellness: results from a randomised, placebo controlled clinical study on adults for osteoarthritis, improvement in skin, nail and health
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Proposal for Clinical Classification of Cutaneous Manifestations in Covid-19 and in Post Vaccination Against Sars-Cov-2: An Observational Study
- Faculty Opinions recommendation of Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose.
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Higher percentage of CD34+ stem cells and elevated efficacy in androgenetic alopecia treatment observed in CGF prepared from 640 nm laser‐pretreated blood: A preliminary study
- Aim to alleviate alopecia areata with newly available agents
- High-Intensity Focused Ultrasound Application to the Scalp to Improve Androgenetic Alopecia in an Adult Woman
- Finasteride improves male pattern hair loss in a randomized study in identical twins.
- Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial
- BPH: costs and treatment outcomes.
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Immunologic adverse reactions of β-blockers and the skin (Review)
- Sex Hormones and Related Compounds, Including Hormonal Contraceptives
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- LB1139 AMP-303 injectable treatment for androgenetic alopecia: A multicenter, randomized, placebo-controlled feasibility study of a novel polysaccharide
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Nitroxide pharmaceutical development for age-related degeneration and disease
- N-acetylcysteine in the treatment of trichotillomania
- Polynucleotides HPT for Asian Skin Regeneration and Rejuvenation
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
- LB1158 A novel more effective topical therapeutic approach for treatment of androgenetic alopecia: First in human trial results for topical ET-02
- Satisfaction of Patients with Androgenetic Alopecia from a Topical Treatment with TH07 - A New Novel Combination of Substances that Safely Encourage Hair Growth